ACNB
ACNB Corporation
ACNB offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
MS
Morgan Stanley
MS has a slight edge over ACNB overall, supported by stronger modeled upside and lower modeled downside.
ACNB Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| N/A | |
| N/A |
ACNB's profitability is currently strong, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like ACNB.
MS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
MS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MS.
ACNB PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 8.3x | $45.14 | -33% |
| Fair | 11x | $58.42 | -13% |
| Current | 12x | $66.92 | — |
| Forward | 12x | $66.92 | — |
| Expensive | 13x | $72.83 | +8.8% |
Historical ranges are pointers, not guarantees.
ACNB has the edge over MS in the historical PE scenario, which offers more potential upside but is not a forecast.
MS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $134 | -29% |
| Fair | 14x | $178 | -5.7% |
| Forward | 14x | $189 | — |
| Current | 15x | $189 | — |
| Expensive | 18x | $223 | +18% |
Historical ranges are pointers, not guarantees.
MS's PE is in its fair range at 15x. If earnings grow as analysts expect, today's price would be 14x next year's earnings.
ACNB Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Stable | |
| Improving | |
| Limited | |
| High |
Analysts expect ACNB's earnings to grow and its profitability to improve, with its revenue holding steady.
MS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
MS has the edge over ACNB on the outlook, with more favorable valuation and revenue expectations.
ACNB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $5.73 | +4.9% |
| Q3 2026 | $5.46 | +67% |
| Q2 2026 | $5.33 | +98% |
| Q1 2026 | $4.95 | +71% |
| Q4 2025 | $3.60 | -3.5% |
| Q3 2025 | $3.27 | -4.7% |
| Q2 2025 | $2.69 | -26% |
| Q1 2025 | $2.90 | -16% |
| Q4 2024 | $3.73 | +0.5% |
ACNB earned $5.46 per share over the past year, up 67% from the year before. Its recent earnings include one-off gains.
MS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.39 | +6.3% |
| Q3 2026 | $12.60 | +29% |
| Q2 2026 | $12.37 | +40% |
| Q1 2026 | $11.04 | +29% |
| Q4 2025 | $10.21 | +28% |
| Q3 2025 | $9.76 | +48% |
| Q2 2025 | $8.84 | +45% |
| Q1 2025 | $8.53 | +55% |
| Q4 2024 | $7.95 | +53% |
MS has the edge over ACNB on earnings, with more consistent year-over-year improvement.
ACNB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $54M | +6.1% |
| Q2 2026 | $52.5M | +4.5% |
| Q1 2026 | $50.5M | +16% |
| Q4 2025 | $47.2M | +42% |
| Q3 2025 | $50.9M | +49% |
| Q2 2025 | $50.3M | +83% |
| Q1 2025 | $43.5M | +66% |
| Q4 2024 | $33.2M | +48% |
ACNB has the edge over MS on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 36% | -0.7 points |
| Q2 2026 | 37% | +7 points |
| Q1 2026 | 34% | +35 points |
| Q4 2025 | 28% | +3.1 points |
| Q3 2025 | 37% | +9.5 points |
| Q2 2025 | 30% | -22 points |
| Q1 2025 | -1.3% | -34 points |
| Q4 2024 | 25% | +3.7 points |
ACNB has the edge over MS on profitability, with a higher operating margin.
MS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.3B | +12% |
| Q2 2026 | $21.3B | +27% |
| Q1 2026 | $20.6B | +16% |
| Q4 2025 | $17.9B | +10% |
| Q3 2025 | $18.2B | +18% |
| Q2 2025 | $16.8B | +12% |
| Q1 2025 | $17.7B | +17% |
| Q4 2024 | $16.2B | +26% |
MS's revenue has grown year over year for 14 quarters in a row: $20.3B last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | -1.2 points |
| Q2 2026 | 34% | +6.9 points |
| Q1 2026 | 34% | +2.8 points |
| Q4 2025 | 32% | +2 points |
| Q3 2025 | 33% | +5.6 points |
| Q2 2025 | 28% | +0.4 points |
| Q1 2025 | 31% | +2.2 points |
| Q4 2024 | 30% | +14 points |
MS's operating margin was 32% last quarter, down 1.2 points from the same quarter a year ago.
ACNB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $46.6M | +105% |
| Q2 2026 | -$4M | -122% |
| Q1 2026 | $24M | +$24.7M |
| Q4 2025 | $12.6M | +136% |
| Q3 2025 | $22.8M | +71% |
| Q2 2025 | $17.9M | +91% |
| Q1 2025 | -$730K | -107% |
| Q4 2024 | $5.3M | -30% |
ACNB has the edge over MS on cash generation, producing positive trailing cash flow while its opponent burns cash.
MS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$46B | -$42.7B |
| Q2 2026 | -$2.7B | -123% |
| Q1 2026 | -$7.1B | +$16.9B |
| Q4 2025 | -$2.4B | -120% |
| Q3 2025 | -$3.3B | +$14B |
| Q2 2025 | $11.8B | +368% |
| Q1 2025 | -$24B | -650% |
| Q4 2024 | $11.8B | +$29.6B |
MS's free cash flow was −$58.3B over the past year, against −$3.7B the year before. Free cash flow isn't a meaningful measure for financial services companies like MS.
ACNB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -44.4K shares |
| 1 year | -2.8% | -288K shares |
| 3 years | +19% | +1.6M shares |
| 5 years | +17% | +1.4M shares |
| Available history | +44% | +3.1M shares |
ACNB has the edge over MS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $742,000 |
| Q2 2026 | $9.2M |
| Q1 2026 | $3.6M |
| Q4 2025 | $2.5M |
| Q3 2025 | $2.7M |
| Q2 2025 | $2.9M |
| Q1 2025 | $3.1M |
| Q4 2024 | — |
ACNB spent $16M buying back its own shares over the past year, up 84% from the year before.
MS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -3M shares |
| 1 year | -1.5% | -24M shares |
| 3 years | -4.7% | -77M shares |
| 5 years | -14% | -246M shares |
| Available history | -4.5% | -74M shares |
MS has 1.6B diluted shares, down 1.5% from a year ago.
ACNB Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.2x | Elevated |
| Q2 2026 | 3.2x | Elevated |
| Q1 2026 | 2.6x | Moderate |
| Q4 2025 | 4.8x | High |
ACNB has the edge over MS on leverage, with a lower net debt burden relative to earnings.
MS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.8x | High |
| Q2 2026 | 7.3x | High |
| Q1 2026 | 8.2x | High |
| Q4 2025 | 8.6x | High |
| Q3 2025 | 8.4x | High |
| Q2 2025 | 8.7x | High |
| Q1 2025 | 8.7x | High |
| Q4 2024 | 7.9x | High |
MS's net debt is about 7.8 years of its operating earnings (EBITDA), down from 8.4 years a year ago. Net leverage isn't a meaningful measure for financial services companies like MS.
ACNB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 70.6 | Overbought |
| Stochastic | 67.0 | Neutral |
ACNB's weekly RSI is 71 (overbought) and its Stochastic is 67 (neutral).
MS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.0 | Neutral |
| Stochastic | 18.7 | Oversold |
MS's weekly RSI is 45 (neutral) and its Stochastic is 19 (oversold).
ACNB PE vs Financial Services Sector
| Metric | ACNB | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 5.8% below |
| PE % | 76 | 63 | 13 pts above |
ACNB has the edge over MS on valuation relative to its sector.
MS PE vs Financial Services Sector
| Metric | MS | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 15% above |
| PE % | 59 | 63 | 4 pts below |
MS is trading at 15x earnings, a 15% premium to the Financial Services sector's median of 13x.
ACNB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $64.6 | 3.7% above |
| 20 week MA | $63.9 | 4.8% above |
| 50 week MA | $56.3 | 19% above |
| 100 week MA | $49.4 | 35% above |
| 200 week MA | $43.1 | 55% above |
ACNB has the edge over MS on trend strength, trading above more of its moving averages.
MS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $186.5 | 1.5% above |
| 20 week MA | $203.3 | 6.9% below |
| 50 week MA | $191.9 | 1.4% below |
| 100 week MA | $164.9 | 15% above |
| 200 week MA | $129.3 | 46% above |
MS's trend is mixed: it's above three of its five weekly moving averages, and 46% above its 200-week average.
ACNB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $37.4 | $25.1 | -33% |
| 2021 | $25.1 | $30.3 | +21% |
| 2022 | $30.3 | $40.3 | +33% |
| 2023 | $40.3 | $44.8 | +11% |
| 2024 | $44.8 | $39.6 | -11% |
| 2025 | $39.6 | $49.4 | +25% |
| 2026 YTD | $49.4 | $66.9 | +35% |
ACNB has the edge over MS on returns for 2026, with the stronger performance.
MS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.1 | $68.1 | +33% |
| 2021 | $68.1 | $99.3 | +46% |
| 2022 | $99.3 | $86.1 | -13% |
| 2023 | $86.1 | $93.3 | +8.3% |
| 2024 | $93.3 | $126.8 | +36% |
| 2025 | $126.8 | $181.9 | +43% |
| 2026 YTD | $181.9 | $189.2 | +4% |
MS has finished higher in five of the last six years. It's up 4% so far in 2026.